Successful Infliximab Therapy in a Patient with Refractory Takayasu's Arteritis
Journal of Rheumatic Diseases
;
: 71-75, 2016.
Artículo
en Inglés
| WPRIM
| ID: wpr-215894
ABSTRACT
Takayasu's arteritis (TA), a granulomatous vasculitis, affects the aorta and its major branches. Glucocorticoids are an effective treatment for patients with active TA, but some patients fail to achieve or maintain remission with the conventional therapy, and side effects resulting from long-term glucocorticoid therapy are potentially serious. Anti-tumor necrosis factor-alpha agents, such as infliximab, may be efficient in patients with refractory TA. We report on a 24-year-old female patient with refractory TA who was treated successfully with infliximab. Clinical remission was induced as determined by repeated 18F-fluoro-2-deoxy-D-glucose positron emission tomography scans combined with assay of serological inflammatory markers.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Aorta
/
Vasculitis
/
Arteritis de Takayasu
/
Tomografía de Emisión de Positrones
/
Infliximab
/
Glucocorticoides
/
Anticuerpos Monoclonales
/
Necrosis
Límite:
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Journal of Rheumatic Diseases
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS